Clinical trial
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
NCT00415506 · Oregon Health and Science University, Other · Completed
Key facts
| NCT number | NCT00415506 |
|---|---|
| Title | Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation |
| Official title | A PhaseI/II Prospective, Randomized, Dose-Ranging Pilot Study of Rituximab in the Treatment of Refractory Scleritis and Non-Infectious Orbital Inflammation |
| Lead sponsor | Oregon Health and Science University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Scleritis, Orbital Disease |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 20 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Dec 25, 2006 |
| Last update posted | Aug 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: